Nancy M. Boulos

Nancy M. Boulos

Auto-generated profile, based on publicly available information

Nancy M. Boulos

Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in BJA Open
Verified
Journal Article
Open access
YGYann Gricourt
Yann Gricourt
NBNancy M. Boulos
Nancy M. Boulos
ADAmelie Delaporte
Amelie Delaporte
BABrenton Alexander
Brenton Alexander
SBStephane Besada
Stephane Besada
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Although opioids are commonly used to relieve pain associated with surgery, they are not consequence free. Moreover, the USA and many western countries are currently experiencing a significant health crisis because of opioid addiction and its related overdose potential. There have been no studies that have evaluated patient preference regarding opioid use and its potential impact on the quality of recovery. The aim of this study is to compare the effect of patient preference on intraoperative opioid use on early postoperative quality of recovery after moderate risk laparoscopic/robotic abdominal surgery. This trial is an interventional, pragmatic, partially randomised factorial trial. Adults (N=240) scheduled for moderate-risk abdominal surgery under laparoscopic/robotic assistance (colorectal, urologic, and gynaecologic) will be allocated into four groups, according to their preference (choice of opioid-free vs opioid-based anaesthesia vs no choice and, if no choice, then the patient is randomised to opioid-based vs opioid-free anaesthesia). Anaesthesia providers and patients who choose their anaesthesia type will be unblinded of the allocation group. The primary endpoint will be the Quality of Recovery-15 score at postoperative day 1. Secondary endpoints will include patient satisfaction, postoperative nausea and vomiting, intraoperative bradycardia, postoperative opioid consumption, postoperative hypoxemia, and health-related quality of life using the EuroQoL 5-Dimension 5-Level (EQ-5D-5L). This trial will provide evidence on whether patient preference on intraoperative opioid use can improve patient quality of recovery after moderate-risk abdominal surgery. NCT06855641. 2.0, 24 February 2025.

15 October 2025 in BJA Open
Verified
Journal Article
Open access
IEInaame Ettoumi
Inaame Ettoumi
DPDaniel Pearce
Daniel Pearce
TWTheodora Wingert
Theodora Wingert
ADAmelie Delaporte
Amelie Delaporte
BABrenton Alexander
Brenton Alexander
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Intraoperative hypotension has been associated with postoperative complications, but its relationship with postoperative delirium remains debated. This single-centre retrospective cohort study included adults (≥60 yr) with ASA physical status score of 3 or 4 undergoing major noncardiac surgery, with documented Confusion Assessment Method assessments. Patients with a history of neurosurgery, stroke, dementia, or neurocognitive disorders were excluded. The primary exposure was the cumulative duration of a mean arterial pressure <65 mm Hg (minutes). The primary outcome was postoperative delirium within 7 days, diagnosed via Confusion Assessment Method. Multivariable logistic regression was used to assess the association between intraoperative hypotension and delirium, adjusting for confounders. Among 5171 patients included from 2013–2024, 632 (11.8%) developed delirium. The median (Q1–Q3) duration of surgery and time with mean arterial pressure <65 mm Hg were 281 (199–430) min and 28 (9–61) min, respectively. In models adjusted for patient characteristics and perioperative factors, intraoperative hypotension was associated with increased odds of delirium (odds ratio per 60 min, 1.12; 95% confidence interval, 1.01–1.24; P=0.038). However, after adjusting for year of surgery, the association was attenuated and no longer statistically significant (odds ratio, 1.06; 95% confidence interval, 0.95–1.18; P=0.320). Both intraoperative hypotension exposure and delirium incidence declined significantly over the study period. Although intraoperative hypotension initially appeared to be associated with postoperative delirium, this association was no longer significant when accounting for temporal improvements in perioperative care. Intraoperative hypotension may represent a marker of historical practice patterns rather than an independent causal driver of delirium.

27 February 2026 in BJA Open
Verified
Journal Article
Open access
GBGabriel Bellouni
Gabriel Bellouni
MCMatthieu Clanet
Matthieu Clanet
KTKarim Touihri
Karim Touihri
ADAmelie Delaporte
Amelie Delaporte
NBNancy M. Boulos
Nancy M. Boulos
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Propofol injection pain is common during i.v. induction and is often accompanied by nociceptive behaviours. Whether this pain is subsequently remembered by patients remains poorly characterised. We aimed to estimate the incidence of postoperative day 1 (POD#1) recall of propofol injection pain and to explore unadjusted associations with patient-, procedure-, and technique-related factors in routine clinical practice. We conducted a pilot prospective observational cohort study of adults undergoing low- to intermediate-risk noncardiac surgery with i.v. propofol induction between March and August 2025 at a single tertiary centre. The primary outcome was patient-reported recall of propofol injection pain on POD#1, assessed via structured interview. Secondary outcomes included recalled pain intensity (0–10 numerical rating scale), comparison with i.v. catheter insertion, and associations with observed nociceptive reactions and injection technique (catheter site, gauge, lidocaine use). All regression analyses were univariate, exploratory, and unadjusted. Among 1043 patients with POD#1 data, 102 patients (9.8%; 95% confidence interval, 8.1–11.8%) recalled propofol injection pain. Recall was more frequent in women in univariate analyses. Catheter site, gauge, and lidocaine use showed no unadjusted associations with recall. Nociceptive reactions were frequent but did not differentiate patients with and without recall. Among patients with recall, median pain intensity was 7/10 (interquartile range, 5–9), and 99% rated pain as equal to or worse than i.v. cannulation. Approximately 10% of patients recalled propofol injection pain on POD#1, typically as severe pain. Female sex showed an unadjusted association with recall, whereas injection technique and observed nociceptive reactions did not.

15 December 2025 in BJA Open
Verified
Journal Article
Open access
YGYann Gricourt
Yann Gricourt
NBNancy M. Boulos
Nancy M. Boulos
YDYann Daoulas
Yann Daoulas
TGTristan Grogan
Tristan Grogan
BABrenton Alexander
Brenton Alexander
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
Opioids remain central to perioperative analgesia but concerns about the growing opioid crisis and adverse effects have prompted revaluation of their role. Opioid-sparing anaesthesia and opioid-free anaesthesia (OFA) have emerged as alternatives, yet their clinical adoption remains uncertain. This survey assessed adoption and perceptions among anaesthesiologists in North America and Europe. A 26-question cross-sectional, web-based survey was distributed via email to members of the American, European, and French Societies of anaesthesiologists. The survey assessed routine use of opioid-sparing techniques, defined as the regular use of non-opioid analgesics and adjuncts to minimise intraoperative opioid use in the past month. We hypothesised that fewer than 50% of anaesthesiologists routinely used these techniques during this period. The overall response rate was 2% among ASA members (614/31 000) and 12% among European Society of Anaesthesiology and Intensive Care (ESAIC) members (414/3500). Concern about opioid use was reported as high in ESAIC and ASA members (90% vs 83%, P<0.001). Daily use of opioid sparing techniques was reported by 37% (95% confidence interval [CI] 32–42%) of ESAIC and 40% (95% CI 36–45%) of ASA members. OFA use was less common overall but reported to be higher by ASA repondents (21%, 95% CI 18–25%) vs 12% (95% CI 9–15%), P<0.001) for EASIC respondents. Perceived risks differed: EASIC respondents more often cited haemodynamic instability (43% vs 16%, P<0.001), whereas ASA respondents more often cited patient dissatisfaction (55% vs 30%) and uncontrolled pain (72% vs 53%, both P<0.001). Key barriers to OFA adoption included limited training, low confidence, and lack of evidence-based guidelines. Interest in opioid-sparing anaesthesia and OFA is widespread, but routine use remains modest and varies by region. Regional perceptions, institutional protocols, and confidence in evidence appear to influence implementation.

20 November 2025 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
Alexandre JoostenAlexandre Joosten
Alexandre Joosten
ADAmelie Delaporte
Amelie Delaporte
NBNancy M. Boulos
Nancy M. Boulos
YGYann Gricourt
Yann Gricourt
Patrice ForgetPatrice Forget
Patrice Forget